文献速递腹部技术与安全

肝细胞癌:转移途径与肝外表现

Hepatocellular carcinoma: metastatic pathways and extra-hepatic findings.
PubMed 文献 · Abdom Radiol (NY) · 2021-06-05

本文讨论肝细胞癌的区域性和全身性转移途径及其推测机制与相关分子异常,并讨论肝外病变的影像学检出对治疗选择和分期的影响;文章还涉及肝外病变在患者管理中的潜在作用。

要点

  • 肝细胞癌早期肝外转移可因病灶小、表现不特异而被影像学漏诊。
  • 肝外扩散经不同途径发生,与肿瘤生物学和分子特征直接相关。
  • 早期准确检出肝外病变对治疗选择与分期有重要影响。

核心结论

  • 肝细胞癌肝外扩散经不同途径发生并受肿瘤生物学与分子特征驱动,早期准确检出肝外病变对治疗选择和精确分期有重要影响。

研究设计与样本

  • 综述性文章,讨论肝细胞癌区域性与全身性转移途径、推测机制及相关分子异常,并讨论其在患者管理中的潜在作用。

诊断标准与关键数值

  • 本文为综述,未报告敏感度、特异度、AUC、阈值或分级标准等诊断数值。

临床应用与阅片要点

  • 对肝细胞癌患者应关注早期肝外转移,因其病灶可能较小且表现不特异而被影像学漏诊。
  • 检出肝外病变有助于治疗选择与精确分期,并可能改善生存与结局的预测。

局限性

  • 原文为综述性文章,未报告原始研究的样本量、置信区间或异质性等数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Although a small portion of patients with hepatocellular carcinoma (HCC) have radiologically evident extrahepatic disease at the initial presentation, a larger number of them develop metastatic disease later during the course of treatment or after definitive treatment. Furthermore, early metastatic disease could be overlooked by imaging due to small size and non-specificity of findings. Extrahepatic spread of HCC occurs via different pathways and is directly fueled by tumor biology and its molecular characteristics. Early and accurate detection of extrahepatic disease in patients with HCC has significant impact on management and selection of treatment options. Additionally, precise staging of disease will allow for better prediction of survival and outcome. Different pathways of regional and systemic spread of HCC with their proposed mechanisms and relevant underlying molecular derangement will be discussed in this article. Potential roles in management of patients with HCC will be discussed and reviewed in this article.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Arora S, Harmath C, Catania R, et al. Hepatocellular carcinoma: metastatic pathways and extra-hepatic findings. Abdom Radiol (NY). 2021. PMID: 34091729. doi:10.1007/s00261-021-03151-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。